Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parabens Flocculation and Corticosteroid Efficacy in Knee Osteoarthritis
NCT03445611Phase 1Withdrawn
- Sponsor
- Loma Linda University
- Start
- Sep 2019
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of betamethasone and triamcinolone acetonide in osteoarthritis (OA) (2 arms), sponsored by Loma Linda University. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 6 months. Planned start Sep 2019; status: withdrawn.
02
Drugs
betamethasonetriamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03445611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03445611.